Kidney Stones & Urinary Mineral Balance
1. Definition and Overview
Kidney stones (calculi) are mineral concretions in the renal calyces and pelvis that are found free or attached to the renal papillae. They are collectively known as nephrolithiasis or urolithiasis, and form when the urine becomes excessively supersaturated with respect to a mineral, leading to crystal formation, growth, aggregation, and retention within the kidneys. The mechanism of stone formation is a complex process which results from several physicochemical events including supersaturation, nucleation, growth, aggregation, and retention of urinary stone constituents within tubular cells — steps modulated by an imbalance between factors that promote or inhibit urinary crystallization.
Kidney stone disease (KSD) is one of the most common urological diseases, and its incidence has increased dramatically in the last few decades. Over the past four decades, the lifetime prevalence of nephrolithiasis has more than doubled in the United States and several other developed countries, afflicting around 11% of men and 7% of women. The etiology is multifactorial, and the recurrence rate is as high as 50% within 5 years after the first stone onset.
2. Presentation and Symptoms
Kidney stones are concretions of different mineral salts mixed with an organic matrix that form in the upper urinary tract. As a stone moves from the kidney to the ureter, it can present with renal colic symptoms and may cause urinary tract obstruction and/or infection. Acute passage of a kidney stone is one of the leading reasons for visits to an emergency room.
After a kidney stone is formed, it can stay in the kidney and not cause issues. Sometimes, kidney stones go down the urinary tract into the ureter. Tiny stones can move out of the body without causing too much pain. However, most of the time kidney stones cause pain as the body works to expel them through the urinary tract.
3. Types of Kidney Stones
3.1 Calcium Oxalate and Calcium Phosphate Stones
Globally, approximately 80% of kidney stones are composed of calcium oxalate (CaOx) mixed with calcium phosphate (CaP). Calcium-containing stones are the most common, with calcium oxalate as the main component of most stones. However, many of these form on a calcium phosphate matrix called Randall's plaque, which is found on the surface of the kidney papilla.
Calcium oxalate kidney stones are usually caused by a combination of diet, genetic, and medical factors. Eating too much sodium, added sugar, and protein from meat, poultry, and fish can cause calcium kidney stones. Not getting enough calcium can also contribute to calcium oxalate kidney stones. Calcium phosphate stones are less common and can form when the urine is too alkaline.
3.2 Uric Acid Stones
Stones composed of uric acid account for approximately 9% of stones. Uric acid is produced when the body metabolizes protein. When the pH of urine drops below 5.5, urine becomes saturated with uric acid crystals. When there is too much uric acid in the urine, stones can form. Uric acid stones are more common in people who consume large amounts of protein, such as that found in red meat or poultry.
3.3 Struvite Stones
Struvite stones are composed of a mixture of magnesium, ammonium, phosphate, and calcium carbonate. These stones form as a result of infection with certain types of bacteria that can produce ammonia. Ammonia acts to raise the pH of urine, which makes it alkaline and promotes the formation of struvite. More common in women, struvite stones form as a result of certain types of urinary tract infections. These stones tend to grow quickly and become large, sometimes occupying the entire kidney. Left untreated, they can cause frequent and sometimes severe urinary tract infections and loss of kidney function.
3.4 Cystine Stones
Cystine stones are rare, and they form only in persons with an inherited metabolic disorder that causes high levels of cystine in the urine, a condition known as cystinuria. It is the result of an autosomal recessive disorder caused by mutations in one of the two genes, either SLC3A1 or SLC7A9, leading to abnormal transport of dibasic amino acids from the luminal fluid of the renal proximal tubules and small intestine. Although the rate of cystine stones is much lower than calcium oxalate stones, cystine stones are larger, recur more frequently, and are more likely to cause chronic kidney disease.
4. Body Systems Involved
Kidney stone disease involves several interconnected physiological systems. Recent studies suggest that nephrolithiasis should be regarded as a systemic disease due to the interaction of multiple risk factors. The primary systems include the renal and urological system (where stones form and travel), the gastrointestinal system (governing absorption of calcium, oxalate, and other minerals), the endocrine system (including parathyroid hormone regulation of calcium), and the metabolic system broadly.
The connection between dietary calcium and oxalate excretion is well established: calcium works as a chelator for both phosphate and oxalate in the gut; thus, a low calcium diet will increase the amount of intestinal free-oxalate ions, favoring its absorption and then its urinary excretion.
Urinary oxalate is derived from two major sources: the diet and endogenous synthesis. Up to 40% of the daily excretion of oxalate in the urine is from dietary sources, but oxalate absorption in the intestine depends linearly on the concomitant dietary intake of calcium and is influenced by the bacterial degradation by several bacterial species of intestinal flora.
5. Contributing and Associated Factors
5.1 Dietary Factors
Poor diet has been identified as a primary cause of kidney stones. Dietary patterns consistent with the typical diet in the United States — characterized by high animal protein, salt, and sugar and low fruits and vegetables — cause undesirable changes to urine chemistry that predispose people to kidney stones. High consumption of proteins, especially of animal origin, leads to increased urine excretion of calcium, oxalate, and uric acid, and lower urine pH and citrate: all of these changes lead to a pro-lithogenic profile.
Dietary sodium load causes an increase in urinary calcium excretion. Thus, a restriction of dietary salt intake (i.e., a salt intake of 5–6 g/day as recommended in a healthy diet) should be suggested for primary and secondary prevention of calcium stone formation.
Only eight foods — spinach, rhubarb, beets, nuts, chocolate, tea, wheat bran, and strawberries — have been shown to cause a significant increase in urinary oxalate excretion in controlled studies. Restriction of dietary calcium enhances oxalate absorption and excretion, whereas an increase in calcium intake may reduce urinary oxalate excretion by binding more oxalate in the gut.
5.2 Fluid Intake
The protective effect of a generous fluid intake was demonstrated in 199 people with idiopathic calcium oxalate stones, randomised to either high fluid intake (sufficient to produce more than 2 L urine daily) compared to control. Maintaining adequate urine volume dilutes stone-forming minerals and is considered a cornerstone of stone prevention across all stone types.
5.3 Obesity, Metabolic Syndrome, and Diabetes
Epidemiologic studies have demonstrated that the stone risk incidence increases with Body Mass Index through multiple pathways. Metabolic syndrome and diabetes are associated with an increased renal stones disease incidence. The underlying pathophysiology of stone formation in obese patients is thought to be related to insulin resistance, dietary factors, and a lithogenic urinary profile. Insulin resistance is thought to alter the renal acid-base metabolism, resulting in a lower urine pH, and increasing the risk of uric acid stone disease.
A large prospective cohort study using UK Biobank data (n = 487,860) concluded that metabolic syndrome is a significant and independent risk factor for the development of kidney stones, and that kidney stones may represent a systemic disorder influenced by the interplay of various metabolic risk factors. After an average follow-up of 12.6 years, the partial traits of metabolic syndrome — including waist circumference, low HDL cholesterol, high blood pressure, and type 2 diabetes — were independently associated with the occurrence of kidney stones.
5.4 Hypocitraturia (Low Urinary Citrate)
The degree of citraturia is mainly determined by changes in acid-base status. In metabolic acidosis with a lower luminal pH in the proximal tubule, the divalent species of citrate becomes much more prevalent, and thus citrate reabsorption from the tubular lumen into the proximal tubular cells increases. Furthermore, the activity of citrate lyase increases during intracellular acidosis, which lowers citrate concentrations within the proximal tubular cells and further favours reabsorption from the tubular fluid. There are also more sodium-dependent citrate transporters in acidosis. The result is reduced urinary citrate, diminishing this important natural inhibitor of crystallization.
5.5 The Gut Microbiome and Oxalate Metabolism
Oxalobacter formigenes is a Gram-negative, anaerobic bacterium that metabolizes oxalate in the intestinal tract and is present in a large proportion of the normal adult population. It was hypothesized that the absence of O. formigenes could lead to increased colonic absorption of oxalate, and the subsequent increase in urinary oxalate could favor the development of stones. Intestinal O. formigenes colonization has been associated with a lower risk for recurrent kidney stones in humans.
Prior antibiotic use has been associated with kidney stone development months or even years later. Although multiple bacterial taxa are able to degrade oxalate in the gut, Oxalobacter formigenes is the only commensal known to use oxalate as its sole energy and carbon source and may be the only specialist oxalate degrader in humans. This bacterium has been the scientific focus of attention in recent years due to numerous reports on its impact on the reduction of oxaluria, resulting in a decreased recurrence risk of calcium oxalate stones by up to 70%. In recent years, attempts have been made to create a probiotic drug with O. formigenes as the main element.
5.6 Genetic and Medical Conditions
Stone composition of uric acid, cystine, or struvite implicates specific metabolic or genetic abnormalities, and knowledge of stone composition may help direct preventive measures. Calcium phosphate stone composition is more likely to be associated with certain medical conditions or medications, such as renal tubular acidosis type 1, primary hyperparathyroidism, medullary sponge kidney, and the use of carbonic anhydrase inhibitors.
6. Nutrients, Herbs, and Natural Ingredients
6.1 Citrate (Potassium Citrate / Potassium-Magnesium Citrate)
Overview: Although CaOx is supersaturated in urine, the formation of renal calculi in healthy people is difficult because of all kinds of inhibitors in urine, including citrate, magnesium, osteopontin, and tyrosine hydroxylase. Citrate is among the most studied natural inhibitors of kidney stone formation.
Scientific Evidence: Multiple clinical trials have demonstrated efficacy of alkali citrate therapy. Potassium-magnesium citrate increased urinary citrate levels and pH, resulting in significantly fewer stone recurrences. Barcelo et al. also found that potassium citrate not only elevated urinary citrate but also consistently raised urinary pH into a range associated with reduced calcium salt crystallization.
Studies have shown that quantities and species of urinary crystals decreased after potassium citrate intake. The mechanism of inhibition of formation of CaOx stones by potassium citrate is possibly due to the complexation of Ca²⁺ with citrate, increase in urine pH, and concentration of urinary inhibitor glycosaminoglycans.
After administration of combined potassium-sodium citrate and magnesium oxide to patients with stones, citrate, magnesium, and potassium levels increased substantially, and oxalate decreased by 66.5%. The ion activity product index of CaOx decreased significantly more after administration of the combination than with either compound alone. The combination of potassium-sodium citrate and magnesium oxide is more effective than either supplement alone in inhibiting the crystallization of CaOx stones. Evidence for potassium citrate in stone prevention is robust and supported by multiple randomized controlled trials; it is recognized as a first-line agent by major urological guidelines.
6.2 Magnesium
Scientific Evidence: Magnesium is recognized as an inhibitor of calcium oxalate crystallization. Magnesium-based formulations such as magnesium potassium citrate may offer added benefits by contributing to the inhibition of calcium oxalate crystallization, although they are less studied and not routinely used as first-line agents. In the clinical trial described above, magnesium oxide supplementation in combination with citrate salts led to measurable reductions in urinary oxalate and CaOx crystallization risk. Evidence is supportive but predominantly from combination (citrate + magnesium) trials rather than magnesium alone, limiting ability to isolate its independent effect.
6.3 Dietary Calcium
Scientific Evidence: An integrative review following PRISMA guidelines concluded that adequate calcium intake (800–1,200 mg/day) reduces intestinal oxalate absorption and, consequently, urinary oxalate excretion. Balanced calcium consumption protects against the risk for kidney stones by reducing intestinal oxalate availability and its urinary excretion. However, calcium supplementation given between meals might increase urinary calcium excretion without the beneficial effect on oxalate. This distinction between dietary calcium and supplemental calcium timing is clinically meaningful and well documented across multiple prospective cohort studies.
6.4 Vitamin B6 (Pyridoxine)
Scientific Evidence: High doses of vitamin B6 may decrease oxalate production, whereas vitamin C can be metabolized to oxalate. Urinary oxalate is an important determinant of calcium oxalate kidney stone formation. A high intake of vitamin B6 was inversely associated with risk of stone formation in a prospective cohort of 85,557 women over 14 years.
It has been reported that vitamin B6 deficiency results in increased production and excretion of oxalate, and supplementation of vitamin B6 has been shown to reduce urinary excretion of oxalate in some studies but not in others. Previous studies investigating the association between intake of vitamin B6 and risk of stones have found conflicting results. Cross-sectional data have found that high levels of vitamin B6 and vitamin D intake were linked to a lower prevalence of kidney stones. Overall, the evidence is suggestive but mixed; high-dose supplementation studies in populations without frank B6 deficiency are limited.
6.5 Vitamin C (Ascorbic Acid)
Scientific Evidence: The relationship between vitamin C and kidney stones is complex and dose-dependent. Oxalate is an end product of the metabolism of vitamin C. Circulating ascorbic acid is converted to an antioxidant in the tissues, resulting in the formation of ascorbyl radicals, which can be converted to dehydroascorbate, an unstable molecule that can break down to oxalate. The increase in the ingestion of ascorbic acid leads to excessive formation of oxalate.
However, at moderate intakes, findings are less clear-cut. In a large prospective cohort, vitamin C intake was not significantly associated with kidney stone risk in women, with the multivariate relative risk for the highest intake group (≥1500 mg/d) versus the lowest being 1.06 (95% CI 0.69–1.64). Routine restriction of vitamin C to prevent stone formation at moderate doses was not supported by this dataset. However, with increasing vitamin C intake, the protective effect may turn into a risk factor at high doses. Clinicians frequently recommend limiting supplemental vitamin C to 90 mg/day in calcium oxalate stone formers, based on evidence that doses above 500 mg increase urinary oxalate excretion.
6.6 Vitamin D
Scientific Evidence: In kidney stone formers, circulating active vitamin D has been found to be increased, whereas higher plasma 25-hydroxycholecalciferol seems to be present only in hypercalciuric patients. The association between nutritional vitamin D supplements and the risk for stone formation is currently not completely understood. However, available evidence might suggest that vitamin D administration worsens the risk for stone formation in patients predisposed to hypercalciuria.
A randomized controlled trial found that high-dose and low-dose vitamin D repletion had no effect on urine calcium excretion or the supersaturation of calcium salts in known stone formers. Kidney stone episodes were described as adverse events in two randomized placebo-controlled clinical trials examining concomitant vitamin D and calcium supplementation. Evidence overall is mixed and context-dependent; supplementation risks may be primarily relevant in patients with underlying hypercalciuria.
6.7 Lemon Juice and Citrus Fruits
Traditional Use: Citrus fruits, particularly lemon, have long been used in folk and empirical dietary traditions to prevent and dissolve kidney stones, based on intuitive recognition of their high acid content and historical observations of increased urination.
Scientific Evidence: Amongst the most commonly consumed citrus fruits, lemons contain the greatest concentrations of citric acid; citric acid concentration in lemon juice (49.2 g/kg) exceeds by approximately five-fold the concentration in orange juice. The citrate supplied with the juice that escapes metabolic degradation in vivo is excreted unchanged in the urine.
Ten small prospective clinical studies found that orange, grapefruit, and lemon juices all increased urinary citrate levels. Only orange and grapefruit juices had an alkalinizing effect, while lemon juice has a protective effect by raising urinary citrate levels, though it lacks the full alkalinizing action.
In a retrospective study of hypocitraturic patients, 10 of 11 patients on lemonade demonstrated increased urinary citrate levels (mean increase +383 mg/day, p <0.05), compared to potassium citrate therapy which yielded a mean increase of +482 mg/day.
Explorative analyses from a prospective randomised PROBE trial suggest that fresh lemon juice supplementation to standard diet might prevent stone recurrence in patients with calcium-oxalate nephrolithiasis; however, treatment effect was likely reduced by progressively declining adherence to lemon juice supplementation. The evidence base for lemon juice is promising but still preliminary; existing studies are small, often retrospective or observational, and the PROBE trial was limited by adherence problems.
6.8 Phyllanthus niruri (Chanca Piedra / "Stone Breaker")
Traditional Use: Chanca piedra (Phyllanthus niruri), known as "Stone Breaker," features prominently in Amazonian and South Asian traditional medicine for renal, hepatic, and urinary tract conditions. The plant has been used as a tea and decoction from leaves, stems, and seeds for generations in Brazil and South Asia, specifically for renal lithiasis.
Scientific Evidence: P. niruri is widely available as a herbal remedy for kidney stones, commonly used in Brazil, and has been widely evaluated in in vitro and in vivo pre-clinical studies as well as a handful of clinical trials. However, data on its clinical efficacy with regard to stone elimination or reduction in size and number are conflicting.
Anti-inflammatory, anti-hyperuricemic, and diuretic properties have been described for this plant. Although many studies have shown the beneficial effects of P. niruri and its potential to inhibit the formation of kidney stones, clinical studies remain scarce. One clinical study at the University of São Paulo administered P. niruri as a dry extract (4.5 g twice daily as an infusion) to patients with urolithiasis over a monitoring period with monthly visits. Evidence in animal and human studies points to enhanced kidney function and potentially reduced oxidative stress and inflammatory markers. The overall evidence base remains weak due to small sample sizes, lack of standardized preparations, and conflicting clinical trial results; further rigorous randomized controlled trials are needed.
6.9 Dietary Plants with Preclinical and Early Clinical Evidence
Several dietary plants have received considerable scientific interest based on available evidence in the context of urolithiasis, including Camellia sinensis (green tea), Rubus idaeus (raspberry), Rubia cordifolia (common madder), Petroselinum crispum (parsley), Punica granatum (pomegranate), Nigella sativa (black cumin), Hibiscus sabdariffa (roselle), and Origanum vulgare (oregano). Besides these dietary plants, phytochemicals — such as catechin, epicatechin, epigallocatechin-3-gallate, diosmin, rutin, quercetin, hyperoside, and curcumin — as antioxidant dietary phyto-phenols were found to be effective for the prevention of urolithiasis in preclinical and laboratory models.
It must be emphasized that retrieved articles in this area have been subclassified into in vitro, in vivo, and clinical studies, with most evidence remaining preclinical. Nutritional plants are considered efficient remedies in the diet that can influence risk of recurrence in calcium oxalate stones. The transition from preclinical to robust clinical evidence for most individual botanicals in this category remains incomplete, and evidence strength should be characterized as preliminary.
7. Dietary and Lifestyle Factors: Authoritative Guidance
7.1 The DASH Diet and Overall Dietary Pattern
The DASH diet, which is high in fruits and vegetables, moderate in low-fat dairy products, and low in animal protein, is an effective dietary alternative and has been associated with a lower risk of calcium oxalate stones. Consuming fruits and vegetables increases the excretion of urinary citrate, which is an inhibitor of stone formation. Taylor et al. prospectively examined the relationship between the DASH diet and the incidence of kidney stones and found that the diet significantly reduced the risk of kidney stones.
The relative risks of occurrence of kidney stones in participants in the highest quintile of the DASH score compared with the lowest quintile were 0.55 (95% CI 0.46–0.65) for men, 0.58 (95% CI 0.49–0.68) for older women, and 0.60 (95% CI 0.52–0.70) for younger women — a marked decrease in kidney stone risk.
A DASH-style diet trial found increased magnesium and citrate excretion and higher urine pH in DASH diet subjects compared to a low-oxalate diet group. A DASH diet may lower the risk of kidney stone formation by increasing urinary citrate excretion and urine volume, and a possible role of unidentified stone inhibitors in dairy products and/or plants was suggested.
7.2 Animal Protein and Purine Intake
Calcium stones are influenced by excessive urine calcium and oxalate levels due to high dietary intake. Uric acid stones, which constitute almost 10–15% of stones, are closely linked to high dietary protein and uric acid intake, and to metabolic acidosis. High dietary salt and protein intake increase urinary calcium excretion and create a subtle metabolic acidosis, both of which may contribute to bone loss and stone formation.
7.3 Dietary Oxalate Management
Adequate calcium intake (800–1,200 mg/day) reduces intestinal oxalate absorption and, consequently, urinary oxalate excretion. Hydration, sodium restriction, and urine alkalinization with citrate are complementary dietary strategies. Limiting dietary oxalate to prevent stones is recommended if habitually high dietary intake of oxalate is identified or if follow-up urine measurements show a decrease in oxalate excretion. Foods rich in oxalate include spinach, rhubarb, nuts, legumes, cocoa, okra, and chocolate.
7.4 Fluid Intake Type and Volume
The cornerstones for prevention are adequate hydration, prevention of urinary oxalate and uric acid overload, regulation of urinary pH to prevent acidic urine, and avoiding low urinary citrate levels. Urine output of at least 2 liters per day is a consistent recommendation across major institutional guidelines for stone prevention.
7.5 Dietary Patterns and Modern "Fad Diets"
Kidney stone disease, with an estimated prevalence of up to 10–14% in industrialized nations, is closely related to obesity and other components of the metabolic syndrome. The increase in prevalence of this ensemble of diseases in recent decades is attributed mainly to changes in lifestyle habits and dietary intake, notably the significant increase in carbohydrate and protein intake. A 2021 systematic review in Nutrients examined popular fad diets and KSD risk, noting substantial variability in different low-carbohydrate and high-protein diets and considerable overlap between them, making single-diet risk characterization difficult.
7.6 Gut Microbiome and Probiotic Considerations
Findings from a 2025 study support future investigations to examine the effectiveness of O. formigenes colonization in reducing urinary oxalate excretion in disease cohorts, including calcium oxalate kidney stone formers with enteric hyperoxaluria. Studies identified significant antibiotic effects on O. formigenes colonization and urinary electrolytes, and showed that overall microbiome structure differed in subjects according to O. formigenes presence. Identifying a consortium of bacterial taxa associated with urinary oxalate may provide clues for the primary prevention of kidney stones in healthy adults. This field is active but largely still at the investigational stage regarding clinical application.
References
Go back